Twenty ExactechGPS® Guided Personalized Surgery Abstracts Accepted into Five Leading Orthopaedic Conferences
11 June 2014 - 10:20PM
Business Wire
Twenty Exactech Knee abstracts, featuring the company’s
breakthrough technology ExactechGPS® Guided Personalized Surgery,
have been accepted into five leading orthopaedic conferences:
- The European Federation of National
Associations of Orthopaedics and Traumatology (EFORT) annual
congress (June 4-6)
- The South Korean Computer Aided
Orthopaedic Surgery (CAOS) annual meeting (June 13-16)
- The International Society for CAOS
annual meeting (June 18-21)
- The European Orthopaedic Research
Society (EORS) annual meeting (July 2-4)
- The International Congress for Joint
Reconstruction (ICJR) Pan Pacific Congress (July 16-19)
“It is a privilege to have the scientific committees at these
well-renowned industry conferences recognize Exactech’s solution
for advanced surgical technologies,” said Laurent Angibaud,
director of Exactech Knee Engineering and Development. “The
selected abstracts cover multiple facets of the ExactechGPS system,
including pre-clinical studies evaluating the effects of bone
deformity on surgical accuracy, a technical paper detailing an
improved algorithm used to accurately compute femoral sizes and a
clinical evaluation on 324 cases using ExactechGPS.”
Speaking on behalf of the clinical evaluation, Gérard Giordano,
MD, of Joseph Ducuing Hospital in Toulouse, France and Exactech
consultant, said, “Literature shows resection accuracy plays a
crucial role in longevity for total knee arthroplasty. The three
sites analysis provided excellent feedback for the accuracy and
reproducibility of the ExactechGPS technology, as well as its
benefit for personalization with specific profiles based on the
patient’s needs, a value-add for the most difficult cases. I find
the pre-operative adjustability and real-time feedback of the
system increases efficiency and ultimately, the performance of the
surgery.”
The abstracts presented during the aforementioned events include
the following studies:
- Evaluation of a new computer guidance
system – new sites
- Evaluation of bone deformity on
accuracy of a computer-assisted guidance system for total knee
arthroplasty
- Evaluation of bone deformity on
alignment discrepancies during total knee arthroplasty using an
image-free computer-assisted guidance system
- Effects of repetitive training
practices using an image-free computer-assisted guidance system on
cognitive and technical skills
- Introducing monitored real-time
patient-specific technique for total knee arthroplasty
- A novel method for accurate
determination of knee prosthesis sizing in total knee arthroplasty
navigation
The Exactech Knee system offers a personalized approach to
surgical techniques that allows for efficiency and reproducibility.
Customized for surgeon preferences, ExactechGPS® Guided
Personalized Surgery is an advanced surgical technology that
presents a real-time patient-specific solution for total knee
replacement.
For more information about the ExactechGPS technology, visit
www.exactechgps.com
About Exactech
Based in Gainesville, Fla., Exactech develops and markets
orthopaedic implant devices, related surgical instruments and
biologic materials and services to hospitals and physicians. The
company manufactures many of its orthopaedic devices at its
Gainesville facility. Exactech’s orthopaedic products are used in
the restoration of bones and joints that have deteriorated as a
result of injury or diseases such as arthritis. Exactech markets
its products in the United States, in addition to more than 30
markets in Europe, Latin America, Asia and the Pacific. Additional
information about Exactech, Inc. can be found at
http://www.exac.com. Copies of Exactech’s press releases, SEC
filings, current price quotes and other valuable information for
investors may be found at http://www.exac.com and
http://www.hawkassociates.com.
An investment profile on Exactech may be found at
http://www.hawkassociates.com/profile/exac.cfm. To receive future
releases in e-mail alerts, sign up at
http://www.hawkassociates.com/about/alert.
This release contains various forward-looking statements within
the meaning of Section 27A of the Securities Act of 1933 and
Section 21E of the Securities Exchange Act of 1934, which represent
the company’s expectations or beliefs concerning future events of
the company’s financial performance. These forward-looking
statements are further qualified by important factors that could
cause actual results to differ materially from those in the
forward-looking statements. These factors include the effect of
competitive pricing, the company’s dependence on the ability of
third party manufacturers to produce components on a basis which is
cost-effective to the company, market acceptance of the company’s
products and the effects of government regulation. Results actually
achieved may differ materially from expected results included in
these statements.
References
1. Data on file at Exactech, Inc. Exactech Knee Literature
Review.
2. Data on file at Exactech.
Exactech Inc.Investor contactsJody Phillips, 352-377-1140Chief
Financial OfficerorHawk AssociatesJulie Marshall or Frank Hawkins,
305-451-1888E-mail: exactech@hawkassociates.comorMedia
contactPriscilla Bennett, 352-377-1140Director Marketing
Communication & Public Relations
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Aug 2024 to Sep 2024
Exactech, Inc. (delisted) (NASDAQ:EXAC)
Historical Stock Chart
From Sep 2023 to Sep 2024